Anbieter: GreatBookPrices, Columbia, MD, USA
Zustand: New.
Anbieter: Romtrade Corp., STERLING HEIGHTS, MI, USA
Zustand: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide.
Zustand: Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service.
Anbieter: SMASS Sellers, IRVING, TX, USA
Zustand: New. Brand New Original US Edition. Customer service! Satisfaction Guaranteed.
Anbieter: Books Puddle, New York, NY, USA
Zustand: New. 1st edition NO-PA16APR2015-KAP.
Anbieter: Majestic Books, Hounslow, Vereinigtes Königreich
EUR 58,89
Anzahl: 4 verfügbar
In den WarenkorbZustand: New.
PAP. Zustand: New. New Book. Shipped from UK. Established seller since 2000.
Anbieter: GreatBookPrices, Columbia, MD, USA
Zustand: As New. Unread book in perfect condition.
EUR 64,99
Anzahl: 2 verfügbar
In den WarenkorbPAP. Zustand: New. New Book. Shipped from UK. Established seller since 2000.
Anbieter: Biblios, Frankfurt am main, HESSE, Deutschland
Zustand: New.
Sprache: Englisch
Verlag: Taylor and Francis Ltd, GB, 2024
ISBN 10: 1032170239 ISBN 13: 9781032170237
Anbieter: Rarewaves.com USA, London, LONDO, Vereinigtes Königreich
EUR 76,30
Anzahl: 1 verfügbar
In den WarenkorbPaperback. Zustand: New. Chronic obstructive pulmonary disease is, of 2024, one of the three main causes of death in the world, affecting around 12% of the world's population. Its incidence is estimated to increase in the coming decades due to continuous exposure to risk factors and to an aging population.Pulmonary emphysema is one of its most serious phenotypes, with chronic and inexorable progression and, in the most severe stages, it is highly disabling and lethal.This book reviews knowledge about the pathophysiology of severe pulmonary emphysema and the current innovative interventional and minimally invasive therapeutic concepts for the management of these advanced stages of emphysema, based on the best scientific evidence.This guide provides to multidisciplinary pulmonary boards of experts in advanced lung diseases, current criteria for the choice of precision therapeutic options and beyond to maintaining optimized medical treatment to controlling lung hyperinflation, and alleviating patients' symptoms.This book is a valuable resource for clinicians dealing with critically ill patients with COPD.
Anbieter: GreatBookPricesUK, Woodford Green, Vereinigtes Königreich
EUR 59,81
Anzahl: 2 verfügbar
In den WarenkorbZustand: New.
Sprache: Englisch
Verlag: Taylor & Francis Ltd, London, 2024
ISBN 10: 1032170239 ISBN 13: 9781032170237
Anbieter: Grand Eagle Retail, Bensenville, IL, USA
Paperback. Zustand: new. Paperback. Chronic obstructive pulmonary disease is, of 2024, one of the three main causes of death in the world, affecting around 12% of the world's population. Its incidence is estimated to increase in the coming decades due to continuous exposure to risk factors and to an aging population.Pulmonary emphysema is one of its most serious phenotypes, with chronic and inexorable progression and, in the most severe stages, it is highly disabling and lethal.This book reviews knowledge about the pathophysiology of severe pulmonary emphysema and the current innovative interventional and minimally invasive therapeutic concepts for the management of these advanced stages of emphysema, based on the best scientific evidence.This guide provides to multidisciplinary pulmonary boards of experts in advanced lung diseases, current criteria for the choice of precision therapeutic options and beyond to maintaining optimized medical treatment to controlling lung hyperinflation, and alleviating patients' symptoms.This book is a valuable resource for clinicians dealing with critically ill patients with COPD. This book reviews knowledge about the pathophysiology of severe pulmonary emphysema and current innovative interventional and minimally invasive therapeutic concepts for the management of these advanced stages of emphysema, based on the best scientific evidence. Shipping may be from multiple locations in the US or from the UK, depending on stock availability.
Sprache: Englisch
Verlag: Taylor and Francis Ltd, GB, 2024
ISBN 10: 1032170239 ISBN 13: 9781032170237
Anbieter: Rarewaves USA, OSWEGO, IL, USA
Paperback. Zustand: New. Chronic obstructive pulmonary disease is, of 2024, one of the three main causes of death in the world, affecting around 12% of the world's population. Its incidence is estimated to increase in the coming decades due to continuous exposure to risk factors and to an aging population.Pulmonary emphysema is one of its most serious phenotypes, with chronic and inexorable progression and, in the most severe stages, it is highly disabling and lethal.This book reviews knowledge about the pathophysiology of severe pulmonary emphysema and the current innovative interventional and minimally invasive therapeutic concepts for the management of these advanced stages of emphysema, based on the best scientific evidence.This guide provides to multidisciplinary pulmonary boards of experts in advanced lung diseases, current criteria for the choice of precision therapeutic options and beyond to maintaining optimized medical treatment to controlling lung hyperinflation, and alleviating patients' symptoms.This book is a valuable resource for clinicians dealing with critically ill patients with COPD.
Anbieter: Chiron Media, Wallingford, Vereinigtes Königreich
EUR 64,85
Anzahl: 2 verfügbar
In den Warenkorbpaperback. Zustand: New.
Anbieter: Ria Christie Collections, Uxbridge, Vereinigtes Königreich
EUR 70,26
Anzahl: 2 verfügbar
In den WarenkorbZustand: New. In.
Anbieter: THE SAINT BOOKSTORE, Southport, Vereinigtes Königreich
EUR 67,90
Anzahl: 1 verfügbar
In den WarenkorbPaperback / softback. Zustand: New. New copy - Usually dispatched within 4 working days.
Anbieter: GreatBookPricesUK, Woodford Green, Vereinigtes Königreich
EUR 68,41
Anzahl: 2 verfügbar
In den WarenkorbZustand: As New. Unread book in perfect condition.
Zustand: New.
Anbieter: Revaluation Books, Exeter, Vereinigtes Königreich
EUR 79,43
Anzahl: 2 verfügbar
In den WarenkorbPaperback. Zustand: Brand New. 192 pages. 10.00x7.00x1.18 inches. In Stock.
Zustand: New.
Verlag: Nimbus. Kunst und Bücher, 2014
ISBN 10: 3038500089 ISBN 13: 9783038500087
Anbieter: Antiquariat UEBUE, Zürich, Schweiz
Softcover. Zustand: Sehr gut. Limitierte Ausgabe. Z : 13 x 22 cm, 160 Seiten - Limitierte Ausgabe No 166/200 Ex. und 167/200.
EUR 59,82
Anzahl: 2 verfügbar
In den WarenkorbZustand: NEW.
Sprache: Englisch
Verlag: TAYLOR & FRANCIS NP EXCLUSIVE(CBS), 2025
ISBN 10: 1032170239 ISBN 13: 9781032170237
Anbieter: UK BOOKS STORE, London, LONDO, Vereinigtes Königreich
EUR 113,73
Anzahl: 13 verfügbar
In den WarenkorbZustand: New. Brand New! Fast Delivery This is an International Edition and ship within 24-48 hours. Deliver by FedEx and Dhl, & Aramex, UPS, & USPS and we do accept APO and PO BOX Addresses. Order can be delivered worldwide within 6-10 days and we do have flat rate for up to 2LB. Extra shipping charges will be requested if the Book weight is more than 5 LB. This Item May be shipped from India, United states & United Kingdom. Depending on your location and availability.
Zustand: New.
Sprache: Englisch
Verlag: Taylor and Francis Ltd, GB, 2024
ISBN 10: 1032170239 ISBN 13: 9781032170237
Anbieter: Rarewaves USA United, OSWEGO, IL, USA
Paperback. Zustand: New. Chronic obstructive pulmonary disease is, of 2024, one of the three main causes of death in the world, affecting around 12% of the world's population. Its incidence is estimated to increase in the coming decades due to continuous exposure to risk factors and to an aging population.Pulmonary emphysema is one of its most serious phenotypes, with chronic and inexorable progression and, in the most severe stages, it is highly disabling and lethal.This book reviews knowledge about the pathophysiology of severe pulmonary emphysema and the current innovative interventional and minimally invasive therapeutic concepts for the management of these advanced stages of emphysema, based on the best scientific evidence.This guide provides to multidisciplinary pulmonary boards of experts in advanced lung diseases, current criteria for the choice of precision therapeutic options and beyond to maintaining optimized medical treatment to controlling lung hyperinflation, and alleviating patients' symptoms.This book is a valuable resource for clinicians dealing with critically ill patients with COPD.
Sprache: Englisch
Verlag: Taylor & Francis Ltd Sep 2024, 2024
ISBN 10: 1032170239 ISBN 13: 9781032170237
Anbieter: AHA-BUCH GmbH, Einbeck, Deutschland
Taschenbuch. Zustand: Neu. Neuware - This book reviews knowledge about the pathophysiology of severe pulmonary emphysema and current innovative interventional and minimally invasive therapeutic concepts for the management of these advanced stages of emphysema, based on the best scientific evidence.
Verlag: Zch., Offizin., 1993
Anbieter: Biblion Antiquariat, Zürich, ZH, Schweiz
4°. 127 S. mit vielen meist farbigen Abb. OLn., OU. Mit Texten von Conradin Wolf: Blickwechsel zwischen den Inseln - zum Werk Walter Ehrismanns und von Sabine Weder-Arlitt: Wahrnehmung ist die Geschichte. - Schönes Exemplar. Sprache: deutsch.
Sprache: Englisch
Verlag: Taylor and Francis Ltd, GB, 2024
ISBN 10: 1032170239 ISBN 13: 9781032170237
Anbieter: Rarewaves.com UK, London, Vereinigtes Königreich
EUR 71,42
Anzahl: 1 verfügbar
In den WarenkorbPaperback. Zustand: New. Chronic obstructive pulmonary disease is, of 2024, one of the three main causes of death in the world, affecting around 12% of the world's population. Its incidence is estimated to increase in the coming decades due to continuous exposure to risk factors and to an aging population.Pulmonary emphysema is one of its most serious phenotypes, with chronic and inexorable progression and, in the most severe stages, it is highly disabling and lethal.This book reviews knowledge about the pathophysiology of severe pulmonary emphysema and the current innovative interventional and minimally invasive therapeutic concepts for the management of these advanced stages of emphysema, based on the best scientific evidence.This guide provides to multidisciplinary pulmonary boards of experts in advanced lung diseases, current criteria for the choice of precision therapeutic options and beyond to maintaining optimized medical treatment to controlling lung hyperinflation, and alleviating patients' symptoms.This book is a valuable resource for clinicians dealing with critically ill patients with COPD.
Sprache: Englisch
Verlag: Taylor & Francis Ltd, London, 2024
ISBN 10: 1032170239 ISBN 13: 9781032170237
Anbieter: AussieBookSeller, Truganina, VIC, Australien
Paperback. Zustand: new. Paperback. Chronic obstructive pulmonary disease is, of 2024, one of the three main causes of death in the world, affecting around 12% of the world's population. Its incidence is estimated to increase in the coming decades due to continuous exposure to risk factors and to an aging population.Pulmonary emphysema is one of its most serious phenotypes, with chronic and inexorable progression and, in the most severe stages, it is highly disabling and lethal.This book reviews knowledge about the pathophysiology of severe pulmonary emphysema and the current innovative interventional and minimally invasive therapeutic concepts for the management of these advanced stages of emphysema, based on the best scientific evidence.This guide provides to multidisciplinary pulmonary boards of experts in advanced lung diseases, current criteria for the choice of precision therapeutic options and beyond to maintaining optimized medical treatment to controlling lung hyperinflation, and alleviating patients' symptoms.This book is a valuable resource for clinicians dealing with critically ill patients with COPD. This book reviews knowledge about the pathophysiology of severe pulmonary emphysema and current innovative interventional and minimally invasive therapeutic concepts for the management of these advanced stages of emphysema, based on the best scientific evidence. Shipping may be from our Sydney, NSW warehouse or from our UK or US warehouse, depending on stock availability.